126 related articles for article (PubMed ID: 38288568)
1. Novel 2-indolinone derivatives as promising agents against respiratory syncytial and yellow fever viruses.
Apaydın ÇB; Göktaş F; Naesens L; Karalı N
Future Med Chem; 2024 Feb; 16(4):295-310. PubMed ID: 38288568
[No Abstract] [Full Text] [Related]
2. Development of antibody-based assays for high throughput discovery and mechanistic study of antiviral agents against yellow fever virus.
Gao Z; Zhang L; Ma J; Jurado A; Hong SH; Guo JT; Rice CM; MacDonald MR; Chang J
Antiviral Res; 2020 Oct; 182():104907. PubMed ID: 32798604
[TBL] [Abstract][Full Text] [Related]
3. Nucleoside Analogs with Antiviral Activity against Yellow Fever Virus.
Zandi K; Amblard F; Amichai S; Bassit L; Tao S; Jiang Y; Zhou L; Ollinger Russell O; Mengshetti S; Schinazi RF
Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31262759
[TBL] [Abstract][Full Text] [Related]
4. Defective Interfering Particles with Broad-Acting Antiviral Activity for Dengue, Zika, Yellow Fever, Respiratory Syncytial and SARS-CoV-2 Virus Infection.
Lin MH; Li D; Tang B; Li L; Suhrbier A; Harrich D
Microbiol Spectr; 2022 Dec; 10(6):e0394922. PubMed ID: 36445148
[TBL] [Abstract][Full Text] [Related]
5. Antiviral activity of indole derivatives.
Giampieri M; Balbi A; Mazzei M; La Colla P; Ibba C; Loddo R
Antiviral Res; 2009 Aug; 83(2):179-85. PubMed ID: 19445965
[TBL] [Abstract][Full Text] [Related]
6. Sofosbuvir inhibits yellow fever virus in vitro and in patients with acute liver failure.
Mendes ÉA; Pilger DRB; Santos Nastri ACS; Malta FM; Pascoalino BDS; Carneiro D'Albuquerque LA; Balan A; Freitas LHG; Durigon EL; Carrilho FJ; Rebello Pinho JR
Ann Hepatol; 2019; 18(6):816-824. PubMed ID: 31594756
[TBL] [Abstract][Full Text] [Related]
7. Yellow fever virus is susceptible to sofosbuvir both in vitro and in vivo.
de Freitas CS; Higa LM; Sacramento CQ; Ferreira AC; Reis PA; Delvecchio R; Monteiro FL; Barbosa-Lima G; James Westgarth H; Vieira YR; Mattos M; Rocha N; Hoelz LVB; Leme RPP; Bastos MM; Rodrigues GOL; Lopes CEM; Queiroz-Junior CM; Lima CX; Costa VV; Teixeira MM; Bozza FA; Bozza PT; Boechat N; Tanuri A; Souza TML
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007072. PubMed ID: 30699122
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of 2'-C-methylcytidine against yellow fever virus in cell culture and in a hamster model.
Julander JG; Jha AK; Choi JA; Jung KH; Smee DF; Morrey JD; Chu CK
Antiviral Res; 2010 Jun; 86(3):261-7. PubMed ID: 20227442
[TBL] [Abstract][Full Text] [Related]
9. Activity of T-1106 in a hamster model of yellow Fever virus infection.
Julander JG; Furuta Y; Shafer K; Sidwell RW
Antimicrob Agents Chemother; 2007 Jun; 51(6):1962-6. PubMed ID: 17420215
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of Yellow Fever Virus replication based on 1,3,5-triphenyl-4,5-dihydropyrazole scaffold: Design, synthesis and antiviral evaluation.
Fioravanti R; Desideri N; Carta A; Atzori EM; Delogu I; Collu G; Loddo R
Eur J Med Chem; 2017 Dec; 141():15-25. PubMed ID: 29028528
[TBL] [Abstract][Full Text] [Related]
11. RNA interference inhibits yellow fever virus replication in vitro and in vivo.
Pacca CC; Severino AA; Mondini A; Rahal P; D'avila SG; Cordeiro JA; Nogueira MC; Bronzoni RV; Nogueira ML
Virus Genes; 2009 Apr; 38(2):224-31. PubMed ID: 19169857
[TBL] [Abstract][Full Text] [Related]
12. In vitro and in vivo antiviral properties of sulfated galactomannans against yellow fever virus (BeH111 strain) and dengue 1 virus (Hawaii strain).
Ono L; Wollinger W; Rocco IM; Coimbra TL; Gorin PA; Sierakowski MR
Antiviral Res; 2003 Nov; 60(3):201-8. PubMed ID: 14638396
[TBL] [Abstract][Full Text] [Related]
13. Differential activity of nucleotide analogs against tick-borne encephalitis and yellow fever viruses in human cell lines.
Binderup A; Galli A; Fossat N; Fernandez-Antunez C; Mikkelsen LS; Rivera-Rangel LR; Scheel TKH; Fahnøe U; Bukh J; Ramirez S
Virology; 2023 Aug; 585():179-185. PubMed ID: 37356253
[TBL] [Abstract][Full Text] [Related]
14. Activity of T-705 in a hamster model of yellow fever virus infection in comparison with that of a chemically related compound, T-1106.
Julander JG; Shafer K; Smee DF; Morrey JD; Furuta Y
Antimicrob Agents Chemother; 2009 Jan; 53(1):202-9. PubMed ID: 18955536
[TBL] [Abstract][Full Text] [Related]
15. An overview on small molecules acting as broad-spectrum agents for yellow fever infection.
Desantis J; Felicetti T; Cannalire R
Expert Opin Drug Discov; 2022 Jul; 17(7):755-773. PubMed ID: 35638299
[TBL] [Abstract][Full Text] [Related]
16. Generation and Application of a Luciferase Reporter Virus Based on Yellow Fever Virus 17D.
Li D; Ye JL; Liu ZY
Virol Sin; 2021 Dec; 36(6):1456-1464. PubMed ID: 34342842
[TBL] [Abstract][Full Text] [Related]
17. Inactivation of Dengue and Yellow Fever viruses by heme, cobalt-protoporphyrin IX and tin-protoporphyrin IX.
Assunção-Miranda I; Cruz-Oliveira C; Neris RL; Figueiredo CM; Pereira LP; Rodrigues D; Araujo DF; Da Poian AT; Bozza MT
J Appl Microbiol; 2016 Mar; 120(3):790-804. PubMed ID: 26759117
[TBL] [Abstract][Full Text] [Related]
18. Bis(Benzofuran-1,3-
Gupta NK; Jayakumar S; Huang WC; Leyssen P; Neyts J; Bachurin SO; Hwu JR; Tsay SC
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293531
[TBL] [Abstract][Full Text] [Related]
19. Tiratricol inhibits yellow fever virus replication through targeting viral RNA-dependent RNA polymerase of NS5.
Ren H; Wang J; Tang H; Qian X; Xia B; Luo Z; Xu Z; Qi Z; Zhao P
Antiviral Res; 2023 Nov; 219():105737. PubMed ID: 37879570
[TBL] [Abstract][Full Text] [Related]
20. AT-752, a double prodrug of a guanosine nucleotide analog, inhibits yellow fever virus in a hamster model.
Lin K; Good SS; Julander JG; Weight AE; Moussa A; Sommadossi JP
PLoS Negl Trop Dis; 2022 Jan; 16(1):e0009937. PubMed ID: 35073319
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
